Skip to main content
. 2020 Jan 3;46(4):884–895. doi: 10.1093/schbul/sbz140

Table 2.

Group Comparison of SPI-A, SIPS, and PANSS Symptoms Between First-Episode Psychosis (FEP), Clinical High Risk (CHR), and Major Depression (MD)

SPI-A symptom % Present (score ≥ 1) χ 2 (df = 2) P Value Post hoc Test Results
A1 Impaired tolerance to unusual, unexpected or specific novel demands 73.9 43.924 < .001 FEP > CHR = MD
A2 Impaired tolerance to certain social everyday situations 74.5 61.369 < .001 FEP > CHR > MD
A3 Impaired tolerance to working under pressure of time or rapidly changing different demands 77.1 49.431 < .001 FEP > CHR > MD
A4 Changes in mood and emotional responsiveness 96.4 4.502 < .001 FEP > CHR = MD
A5 Decrease in positive emotional responsiveness toward others 85.1 6.852 < .001 FEP = CHR > MD
B1 Inability to divide attention a 41.8 48.562 < .001 FEP > CHR > MD
B2 Feeling overly distracted by stimuli 47.4 38.561 < .001 FEP = CHR > MD
B3 Difficulties concentrating 90.6 25.877 < .001 FEP > CHR > MD
B4 Difficulties to hold things in mind for less than half an hour 62.6 43.837 < .001 FEP = CHR > MD
B5 Slowed-down thinking 62.6 15.096 < .001 FEP = CHR > MD
B6 Lack of thought energy. Purposive thoughts 64.2 40.345 < .001 FEP > CHR > MD
C1 Increased indecisiveness with regard to insignificant choices between equal alternatives 61.5 21.128 < .001 FEP = CHR > MD
C2 Thought interference (B) 47.6 65.711 < .001 FEP > CHR > MD
C3 Thought blockages 55.9 69.661 < .001 FEP = CHR > MD
C4 Disturbance of receptive speech 54.4 82.030 < .001 FEP = CHR > MD
C5 Disturbance of expressive speech 55.2 45.540 < .001 FEP = CHR > MD
C6 Disturbance of immediate recall 53.8 59.286 < .001 FEP = CHR > MD
D1 Decreased capacity to discriminate between different kinds of emotions 35.0 21.937 < .001 FEP = CHR > MD
D2 Increased emotional reactivity in response to routine social interactions 82.8 19.381 < .001 FEP > CHR = MD
D3 Thought pressure (B) 51.7 98.630 < .001 FEP > CHR > MD
D4 Unstable ideas of reference 56.4 122.866 < .001 FEP > CHR > MD
D5 Changed perception of the face or body of others 13.1 19.244 < .001 FEP > CHR > MD
E1 Bodily sensations of numbness and stiffness 15.6 11.682 .003 FEP > CHR = MD
E2 Bodily sensations of pain in a distinct area 17.5 8.668 .013 FEP = CHR > MD
E3 Bodily sensations migrating through the body 5.3 6.061 .048 FEP = CHR > MD
E4 Bodily sensations of being electrified 8.2 3.508 .173 FEP = CHR = MD
E5 Bodily sensations of movement or pressure 1.1 16.971 < .001 FEP = CHR > MD
E6 Bodily sensations of body/body parts changing size 8.3 8.433 .015 FEP = CHR > MD
F1 Hypersensitivity to light / optic stimuli 29.8 10.791 .005 FEP = CHR > MD
F2 Photopsia 10.2 4.868 .088 FEP = CHR = MD
F3 Micropsia. Macropsia 4.1 3.885 .143 FEP = CHR = MD
F4 Hypersensitivity to sounds/noise (B) 50.7 41.968 < .001 FEP = CHR > MD
F5 Changed intensity/quality of acoustic stimuli (B) 33.5 56.320 < .001 FEP > CHR > MD
F6 Somatopsychic bodily depersonalization 8.1 30.187 < .001 FEP = CHR > MD
O1 Thought perseveration 45.6 59.855 < .001 FEP > CHR > MD
O4.10 Partial seeing including tubular vision 8.1 8.753 .013 FEP = CHR > MD
O11 Loss of automatic skills 17.4 9.079 .011 FEP = CHR > MD
SIPS symptom % Present (score ≥ 1) χ 2 (df = 2) P Value Post hoc Test Results
P1 Unusual thought content / delusional ideas (B) 64.1 327.979 < .001 FEP > CHR > MD
P2 Suspiciousness / persecutory ideas (B) 56.5 224.593 < .001 FEP > CHR > MD
P3 Grandiosity 16.7 48.092 < .001 FEP > CHR > MD
P4 Perceptual abnormalities / hallucinations (C) 51.5 169.359 < .001 FEP > CHR > MD
P5 Disorganized communication (C) (B) 44.6 176.170 < .001 FEP > CHR > MD
N1 Social anhedonia or withdrawal (B) 73.7 88.458 < .001 FEP > CHR > MD
N2 Avolition 76.1 31.594 < .001 FEP > CHR > MD
N3 Decreased expression of emotion 48.6 71.400 < .001 FEP > CHR > MD
N4 Decreased experience of emotions and self 49.6 41.103 < .001 FEP > CHR > MD
N5 Decreased ideational richness 39.8 74.304 < .001 FEP > CHR > MD
N6 Deterioration in role functioning (B) 65.6 144.901 < .001 FEP > CHR > MD
D1 Odd behavior or apperance (B) 25.1 82.437 < .001 FEP > CHR > MD
D2 Bizarre thinking 29.5 147.272 < .001 FEP > CHR > MD
D3 Trouble with focus and attention 54.3 59.859 < .001 FEP > CHR > MD
D4 Personal hygiene / social attentiveness 36.4 65.281 < .001 FEP > CHR = MD
G1 Sleep disturbance 67.8 57.949 < .001 FEP > CHR > MD
G2 Dysphoric mood 83.3 41.442 < .001 FEP > CHR > MD
G3 Motor disturbances 26.6 43.137 < .001 FEP > CHR > MD
G4 Impaired tolerance to normal stress 62.2 92.888 < .001 FEP > CHR > MD
PANSS symptom % Present (score ≥ 2) χ 2 (df = 2) P Value Post hoc Test Results
P1 Delusions (C) (B) 54.1 323.187 < .001 FEP > CHR > MD
P2 Conceptual disorganization (B) 42.5 158.552 < .001 FEP > CHR > MD
P3 Hallucinatory behavior (C) 42.3 178.026 < .001 FEP > CHR > MD
P4 Excitement (B) 49.6 115.759 < .001 FEP > CHR > MD
P5 Grandiosity 14.1 60.153 < .001 FEP > CHR > MD
P6 Suspiciousness (B) 52.0 215.481 < .001 FEP > CHR > MD
P7 Hostility (B) 22.4 74.665 < .001 FEP > CHR > MD
N1 Blunted affect (B) 46.4 128.659 < .001 FEP > CHR > MD
N2 Emotional withdrawal (B) 49.4 99.024 < .001 FEP > CHR > MD
N3 Poor rapport (B) 46.1 118.884 < .001 FEP > CHR > MD
N4 Passive-apathetic social withdrawal 68.9 99.547 < .001 FEP > CHR > MD
N5 Difficulty in abstract thinking (B) 33.5 115.227 < .001 FEP > CHR > MD
N6 Lack of spontaneity & flow of conversation 40.0 46.614 < .001 FEP > CHR > MD
N7 Stereotyped thinking (B) 41.6 137.145 < .001 FEP > CHR > MD
G1 Somatic concern 45.0 17.682 < .001 FEP > CHR > MD
G2 Anxiety 59.8 69.127 < .001 FEP > CHR > MD
G3 Guilt feelings 37.8 2.800 .247 FEP > CHR = MD
G4 Tension 79.1 71.219 < .001 FEP > CHR > MD
G5 Manierisms & posturing 15.8 59.638 < .001 FEP > CHR > MD
G6 Depression (B) 80.8 2.082 .353 FEP > CHR = MD
G7 Motor retardation 42.7 28.285 < .001 FEP > CHR = MD
G8 Uncooperativeness 19.6 46.924 < .001 FEP > CHR = MD
G9 Unusual thought content 33.7 144.471 < .001 FEP > CHR > MD
G10 Disorientation 7.4 33.679 < .001 FEP > CHR = MD
G11 Poor attention 44.5 80.760 < .001 FEP > CHR > MD
G12 Lack of judgement & insight 27.7 91.450 < .001 FEP > CHR > MD
G13 Disturbance of volition 28.8 34.491 < .001 FEP > CHR > MD
G14 Poor impulse control 37.5 23.121 < .001 FEP > CHR = MD
G15 Preoccupation 45.7 53.959 < .001 FEP > CHR > MD
G16 Active social avoidance 53.9 85.310 < .001 FEP > CHR > MD

Note: Kruskal-Wallis H-test and post hoc Mann-Whitney U-test (2-tailed alpha > 0.05) were used.

a Bold indicates SPI-A symptoms that are part of the basic symptom criteria, and SIPS and PANSS symptoms included in ultra-high-risk criteria. (B): bridge symptom. (C): central symptom.